| PERIOD ENDING | 28-Feb-09 | 30-Nov-08 | 31-Aug-08 | 31-May-08 | | Total Revenue | 593,063 | 1,278,048 | 1,106,540 | 1,127,916 | | Cost of Revenue | 568,919 | 1,469,194 | 1,605,710 | 872,949 | | | Gross Profit | 24,144 | (191,146) | (499,170) | 254,967 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 129,208 | 31,299 | (297,943) | 339,781 | | Non Recurring |
-
| (5,600) | 5,600 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (105,064) | (216,845) | (206,827) | (84,814) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (47,834) |
-
| 69,667 | (69,667) | | Earnings Before Interest And Taxes | (154,081) | (94,950) | (139,102) | (173,182) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (154,081) | (94,950) | (139,102) | (173,182) | | Income Tax Expense | 1,848 | 716,039 | (50,138) | (52,266) | | Minority Interest | 1,734 | (4,903) | 9,016 | 218 | | | | Net Income From Continuing Ops | (155,929) | (810,989) | (88,964) | (120,916) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (155,929) | (810,989) | (88,964) | (120,916) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($155,929) | ($810,989) | ($88,964) | ($120,916) |
|
0.45% Nasdaq 
0.20%
Income Statement
